Beam Therapeutics Inc. (BEAM)
NASDAQ · Healthcare
Beam Therapeutics Inc. Operating Income 2019–2025
Beam Therapeutics Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Beam Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -107.2 M, a 10.12% decrease year-over-year.
- Beam Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -473.5 M, a 11.72% increase year-over-year.
- Beam Therapeutics Inc. annual operating income for 2025 was -383.7 M, a 7.67% decrease from 2024.
- Beam Therapeutics Inc. annual operating income for 2024 was -415.6 M, a 135.47% increase from 2023.
- Beam Therapeutics Inc. annual operating income for 2023 was -176.5 M, a 47.86% decrease from 2022.
- Beam Therapeutics Inc. annual operating income for 2022 was -338.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Beam Therapeutics Inc. Operating Income — FAQ
Beam Therapeutics Inc. (BEAM) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Beam Therapeutics Inc.'s operating income?
Beam Therapeutics Inc. (BEAM) reported operating income of -$384M for fiscal 2025.
Where can I see BEAM's operating income history?
The chart and table above show Beam Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.